Stroke — Spinal Plasticity to Reduce Hand Impairment After Stroke
Citation(s)
Bunday KL, Perez MA Motor recovery after spinal cord injury enhanced by strengthening corticospinal synaptic transmission. Curr Biol. 2012 Dec 18;22(24):2355-61. doi: 10.1016/j.cub.2012.10.046. Epub 2012 Nov 29. Erratum in: Curr Biol. 2013 Jan 7;23(1):94.
Lum PS, Mulroy S, Amdur RL, Requejo P, Prilutsky BI, Dromerick AW Gains in upper extremity function after stroke via recovery or compensation: Potential differential effects on amount of real-world limb use. Top Stroke Rehabil. 2009 Jul-Aug;16(4):237-53. doi: 10.1310/tsr1604-237.
Marsden J, Greenwood R Physiotherapy after stroke: define, divide and conquer. J Neurol Neurosurg Psychiatry. 2005 Apr;76(4):465-6.
Taylor JL, Martin PG Voluntary motor output is altered by spike-timing-dependent changes in the human corticospinal pathway. J Neurosci. 2009 Sep 16;29(37):11708-16. doi: 10.1523/JNEUROSCI.2217-09.2009.
TWITCHELL TE The restoration of motor function following hemiplegia in man. Brain. 1951 Dec;74(4):443-80.
Spinal Plasticity to Reduce Hand Impairment After Stroke
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
